The symposium took place during the 2024 European Society for Medical Oncology (ESMO) Congress in Barcelona, Spain, with the ...

A while back, pharmaphorum web editor Nicole Raleigh spoke with Daniel Schwenk, senior principal clinical data manager at Boehringer Ingelheim, and Andrea Kloeble, Product Owner, Boehringer ...

The entry of larger companies into the pet insurance market is expected to increase competition. For example, in December 2023, Embrace Pet Insurance insured approximately 600,000 pets nationwide. As ...

That's just because it's owner-reported rather than a steady ... got an animal health business in there. BI is Boehringer Ingelheim, again a conglomerate-- human health and animal health ...

In 2021, the pair teamed up with Verily, the healthcare subsidiary of Google owner Alphabet ... on DTx candidates for schizophrenia with Boehringer Ingelheim and with Indivior on software to ...

For example, Ken Opengart, owner of 3 Birds Consulting ... senior key account manager at Boehringer Ingelheim, provided updates on various diseases that plague the poultry industry.

Boehringer Ingelheim, JB Therapeutics, Sanofi-Aventis, Novartis, UCB, GSK, Array Biopharma and Active Biotech in the area of potential treatments of SSc and is stock owner of 4D Science GmbH.

Competing interests JHWD has consultancy relationships and/or has received research funding from Boehringer Ingelheim, Celgene ... area of potential treatments of scleroderma and is stock owner of 4D ...

Abdulla also aims to further strengthen relationships with regional governments and key healthcare stakeholders to ensure sustainable patient access to Boehringer Ingelheim’s portfolio of leading ...

After antibody-drug conjugate (ADC) specialist Seagen was sold to Pfizer last year for a whopping $43 billion, former CEO David Epstein ...

Notable Labs’ attempts to take a Boehringer Ingelheim cancer drug to market appear to have come to end with the oncology-focused platform company’s decision to file for bankruptcy. Notable's ...

The state-of-the-art research and development center in Georgia will help improve the health and wellbeing of animals Boehringer Ingelheim shared earlier this month that it has officially opened the ...